Latest News

Go Back

Newsletter: Q3/Q4 2019

December 17, 2019 Celerion

« NASH Pathway to Approval – Light at the End of the Tunnel

Celerion Expands Clinical Research to Nebraska Innovation Campus »

Celerion 2026. All Rights Reserved. Privacy & Legal